A Milestone for BioXcellerator
We are delighted to share that our manuscript, “Cryopreserved Exosomes Derived from Hypoxic Wharton’s Jelly Mesenchymal Stromal Cells Enhance Fibroblast Proliferation, Upregulate COL1A2 Expression, and Mitigate Senescence,” has been accepted for publication in Frontiers in Medicine.
This work represents a significant step forward for our research team, highlighting the potential of hypoxia-conditioned, cryopreserved exosomes in regenerative and cellular therapy applications.
We are currently moving through the editorial and production stages toward official publication, and we look forward to sharing the final version once it becomes publicly available.
Visit our Clinical Studies page for past Scientific Presentations, Published Research, and Patient-Reported Outcomes.
